← Back to Search

Embolization Agent

Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams

N/A
Waitlist Available
Led By Cliff Davis, MD
Research Sponsored by Tampa General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test the effectiveness of a new treatment for enlarged prostate that is causing urinary problems.

Eligible Conditions
  • Enlarged Prostate

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Prostate Artery EmbolizationExperimental Treatment1 Intervention
Embospheres microspheres

Find a Location

Who is running the clinical trial?

Tampa General HospitalLead Sponsor
21 Previous Clinical Trials
4,247 Total Patients Enrolled
Cliff Davis, MDPrincipal InvestigatorTampa General Hospital
~3 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top